131 related articles for article (PubMed ID: 1338281)
1. Cytostatic activity of cisplatin in the presence of WR2721 and its thiol metabolite WR1065 in OVCAR-3 human ovarian cancer cells as compared to V79 fibroblasts.
Treskes M; Nijtmans L; Fichtinger-Schepman AM; van der Vijgh WJ
Anticancer Res; 1992; 12(6B):2261-5. PubMed ID: 1338281
[TBL] [Abstract][Full Text] [Related]
2. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
Treskes M; Nijtmans LG; Fichtinger-Schepman AM; van der Vijgh WJ
Biochem Pharmacol; 1992 Mar; 43(5):1013-9. PubMed ID: 1313234
[TBL] [Abstract][Full Text] [Related]
3. The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278.
Treskes M; Holwerda U; Nijtmans LG; Pinedo HM; van der Vijgh WJ
Cancer Chemother Pharmacol; 1992; 29(6):467-70. PubMed ID: 1314713
[TBL] [Abstract][Full Text] [Related]
4. Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse.
Treskes M; Boven E; Holwerda U; Pinedo HM; van der Vijgh WJ
Cancer Res; 1992 Apr; 52(8):2257-60. PubMed ID: 1313740
[TBL] [Abstract][Full Text] [Related]
5. The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin.
Treskes M; Holwerda U; Klein I; Pinedo HM; van der Vijgh WJ
Biochem Pharmacol; 1991 Nov; 42(11):2125-30. PubMed ID: 1659819
[TBL] [Abstract][Full Text] [Related]
6. In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.
Verstappen CC; Geldof AA; Postma TJ; Heimans JJ
J Neurooncol; 1999 Aug; 44(1):1-5. PubMed ID: 10582662
[TBL] [Abstract][Full Text] [Related]
7. Differential radioprotection of cultured human diploid fibroblasts and fibrosarcoma cells by WR1065.
Zhang X; Lai PP; Taylor YC
Int J Radiat Oncol Biol Phys; 1992; 24(4):713-9. PubMed ID: 1429096
[TBL] [Abstract][Full Text] [Related]
8. Protection against cis-diamminedichloroplatinum cytotoxicity and mutagenicity in V79 cells by 2-[(aminopropyl)amino]ethanethiol.
Nagy B; Dale PJ; Grdina DJ
Cancer Res; 1986 Mar; 46(3):1132-5. PubMed ID: 3943091
[TBL] [Abstract][Full Text] [Related]
9. Effects of the modulating agent WR2721 on myelotoxicity and antitumour activity in carboplatin-treated mice.
Treskes M; Boven E; van de Loosdrecht AA; Wijffels JF; Cloos J; Peters GJ; Pinedo HM; van der Vijgh WJ
Eur J Cancer; 1994; 30A(2):183-7. PubMed ID: 8155393
[TBL] [Abstract][Full Text] [Related]
10. WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
Treskes M; van der Vijgh WJ
Cancer Chemother Pharmacol; 1993; 33(2):93-106. PubMed ID: 8261581
[TBL] [Abstract][Full Text] [Related]
11. The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway.
North S; El-Ghissassi F; Pluquet O; Verhaegh G; Hainaut P
Oncogene; 2000 Feb; 19(9):1206-14. PubMed ID: 10713709
[TBL] [Abstract][Full Text] [Related]
12. Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugs.
Kataoka Y; Murley JS; Baker KL; Grdina DJ
Radiat Res; 2007 Jul; 168(1):106-14. PubMed ID: 17723002
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective Role of Selected Antioxidant Agents in Preventing Cisplatin-Induced Damage of Human Neurons In Vitro.
Popović J; Klajn A; Paunesku T; Ma Q; Chen S; Lai B; Stevanović M; Woloschak GE
Cell Mol Neurobiol; 2019 Jul; 39(5):619-636. PubMed ID: 30874981
[TBL] [Abstract][Full Text] [Related]
14. Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065.
Murley JS; Kataoka Y; Weydert CJ; Oberley LW; Grdina DJ
Free Radic Biol Med; 2006 Mar; 40(6):1004-16. PubMed ID: 16540396
[TBL] [Abstract][Full Text] [Related]
15. The radioprotector WR1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells.
Grdina DJ; Nagy B; Hill CK; Wells RL; Peraino C
Carcinogenesis; 1985 Jun; 6(6):929-31. PubMed ID: 4006082
[TBL] [Abstract][Full Text] [Related]
16. Properties of wr2721 (ethiofos) as modulator of Cisplatin-induced neurotoxicity studied at the ultrastructural level in the pond snail lymnaea-stagnalis.
Muller L; Moorervandelft C; Treskes M; Vermorken J; Vandervijgh W; Boer H
Int J Oncol; 1993 Apr; 2(4):701-10. PubMed ID: 21573614
[TBL] [Abstract][Full Text] [Related]
17. Radioprotectors as late preventive agents against carbon tetrachloride induced liver necrosis: protection by 2-(3-aminopropylamino) ethylphosphorothioic acid (WR2721).
Valles EG; de Castro CR; Castro JA
Exp Mol Pathol; 1995 Oct; 63(2):101-9. PubMed ID: 8941044
[TBL] [Abstract][Full Text] [Related]
18. The effect of 2-[(aminopropyl)amino] ethanethiol (WR1065) on radiation-induced DNA damage and repair and cell progression in V79 cells.
Grdina DJ; Nagy B
Br J Cancer; 1986 Dec; 54(6):933-41. PubMed ID: 3801289
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells.
Grdina DJ; Murley JS; Kataoka Y; Calvin DP
Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):103-11. PubMed ID: 11917294
[TBL] [Abstract][Full Text] [Related]
20. WR1065 conjugated to thiol-PEG polymers as novel anticancer prodrugs: broad spectrum efficacy, synergism, and drug resistance reversal.
Walker DM; Lazarova TI; Riesinger SW; Poirier MC; Messier T; Cunniff B; Walker VE
Front Oncol; 2023; 13():1212604. PubMed ID: 37576902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
